![]() |
Malignant Melanoma |
Free Subscription
1 Biochem Biophys Res Commun |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Malignant Melanoma is free of charge.
Inhibition of BCL-2 and MCL-1 disrupts mitochondrial respiration and overcomes
radioresistance in choroidal melanoma.
Biochem Biophys Res Commun. 2025;784:152650.
PubMed
Abstract available
BRAF testing for melanoma in England.
Br J Dermatol. 2025 Sep 12:ljaf373. doi: 10.1093.
PubMed
Disease-Specific Survival of Patients with Amelanotic and Melanotic Melanoma.
J Am Acad Dermatol. 2025 Sep 19:S0190-9622(25)02870.
PubMed
Response to Joshi et al., "Disease-Specific Survival of Patients with Amelanotic
and Melanotic Melanoma".
J Am Acad Dermatol. 2025 Sep 19:S0190-9622(25)02871.
PubMed
A Metabolism-Driven Prognostic Model and PSMD14-SP1-GYS1 Axis Reveal Therapeutic
Vulnerabilities in Melanoma.
J Invest Dermatol. 2025 Sep 16:S0022-202X(25)02430.
PubMed
Abstract available
Thank you for your interest in scientific medicine.